Related Practice Life Sciences & Pharma Immuno-oncology has significant diagnostic needs including identifying patients most likely to respond to therapies. 08012019170843
Executive Insights Organization & Performance Disruptive Trends in Corporate Transformation: Converting Ideas Into Action August 23, 2023
Executive Insights Biotech and Pharmaceuticals The Power of Prediction: How Generative AI Can Drive Biopharma Strategy May 30, 2023
Article Diagnostic & Ancillary Provider & Service Digital Transformation of the Laboratory April 21, 2023
Executive Insights Life Sciences & Pharma NHS (National Health Service): On the Road to Net-Zero by 2045 April 6, 2023
Article Mental and Behavioral Health A Test of Resilience: Looking Forward to Psychedelics Funding in 2023 March 7, 2023
